Transdermal products can cause local skin irritation, contact dermatitis, erythema (redness), pruritus (itching), or allergic sensitisation at the application site
Some clinicians use "plateau" to describe the eventual leveling off at maximum weight loss (around 24 months for most GLP-1 medications) and "stall" for temporary pauses that occur during the active weight loss phase
Heart problems, including signs of rapid weight gain, general swelling or feeling like you're short of breath
DSIP has been studied for various potential physiological roles, including: Stress response and adaptation Pain modulation Immune system regulation Antioxidant properties Effects on endocrine function DSIP has been investigated for potential applications in sleep disorders, pain management, and substance withdrawal syndromes
Factors like diet, stress, and nutrient absorption all influence B12 levels
Acylcarnitines at the membrane surface: insertion parameters for a mitochondrial leaflet model